설명

Insulin resistance markers assessed in berberine-treated NAFLD model organisms indicate improved glucose tolerance and enhanced insulin signaling, suggesting restoration of metabolic homeostasis.

Figure 17

Chart

Source Paper

Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature.

International journal of molecular sciences (2024)

PMID: 38673787

DOI: 10.3390/ijms25084201

Cite This Figure

![Figure 17: Insulin resistance markers assessed in berberine-treated NAFLD model organisms indicate improved glucose tolerance and enhanced insulin signaling, suggesting restoration of metabolic homeostasis.]()

> Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." *International journal of molecular sciences*, 2024. PMID: [38673787](https://pubmed.ncbi.nlm.nih.gov/38673787/)

<figure>
  <img src="" alt="Insulin resistance markers assessed in berberine-treated NAFLD model organisms indicate improved glucose tolerance and enhanced insulin signaling, suggesting restoration of metabolic homeostasis." />
  <figcaption>Figure 17. Insulin resistance markers assessed in berberine-treated NAFLD model organisms indicate improved glucose tolerance and enhanced insulin signaling, suggesting restoration of metabolic homeostasis.<br>  Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." <em>International journal of molecular sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38673787/">38673787</a></figcaption>
</figure>

설명

Figure 17

Source Paper

Cite This Figure

관련 근거